Standout Papers

Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for... 2017 2026 2020 2023 370
  1. Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT (2017)
    Matthias Eiber, Ken Herrmann et al. Journal of Nuclear Medicine
  2. Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2) (2023)
    Robert Seifert, Louise Emmett et al. European Urology

Immediate Impact

1 from Science/Nature 55 standout
Sub-graph 1 of 20

Citing Papers

Prostate Cancer
2025 Standout
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
6 intermediate papers

Works of Matthias Eiber being referenced

Matched-Pair Comparison of 68Ga-PSMA-11 and 18F-rhPSMA-7 PET/CT in Patients with Primary and Biochemical Recurrence of Prostate Cancer: Frequency of Non–Tumor-Related Uptake and Tumor Positivity
2020
Treatment Outcome, Toxicity, and Predictive Factors for Radioligand Therapy with 177Lu-PSMA-I&T in Metastatic Castration-resistant Prostate Cancer
2018
and 8 more

Author Peers

Author Last Decade Papers Cites
Matthias Eiber 4312 3952 1098 191 5.9k
Jérémie Calais 2577 3360 1271 209 4.6k
Louise Emmett 2764 4072 1037 181 5.3k
Paolo Castellucci 2946 3529 1245 189 5.8k
Andrei Iagaru 2758 2042 1303 231 4.8k
Kambiz Rahbar 3595 3883 1515 152 5.1k
Maria Picchio 3889 4270 861 193 7.2k
Michael Souvatzoglou 4155 3354 630 89 6.0k
Ludwig G. Strauss 3030 1569 1307 139 5.1k
Hossein Jadvar 2354 2110 866 169 4.4k
Ali Afshar‐Oromieh 6644 6724 1934 137 8.9k

All Works

Loading papers...

Rankless by CCL
2026